Many patients participate in the PCOS Sisters Metabolic Weight Loss Program , which combines GLP-1 medications with lifestyle management and PCOS-specific metabolic support
Presented for research literature review only Chao AM et al
In addition to improving blood sugar control and promoting weight loss, semaglutide has also been shown to reduce the risk of major cardiovascular events, such as heart attack and stroke, in people with type 2 diabetes
Co-administration in research models would not produce additive receptor-level effects through distinct binding sites, a consideration that distinguishes this pair from, for example, ipamorelin combined with a GHRH receptor agonist such as sermorelin or CJC-1295
Specifically, the activity of the SLC7A11, SLC3A2, and GYS1 genes increases, whereas the activity of the OXSM, NUBPL, NDUFA11, NCKAP1, and LRPPRC genes decreases (Zhu et al., 2023) (Table 1)
That's what we're told